This special issue focused on advancements in biomaterials and clinical translation. This issue intends to cover the recent improvement in designing and developing sustainable implants leading to their commercialization; however, innovation to commercialization is a giant step, and currently, the progress is almost at a standstill.
The researchers have explored various biomaterials to study alternatives to regeneration or replacement of damaged human tissue disease caused due to injury or chronic diseases such as diabetic ulcers, aneurysms, trauma injuries, etc.). The progress in emerging biomaterials has increased manifold in recent decades with the unprecedented focus on healthcare technologies and their commercialization. Because of their excellent mechanical strength, metallic and ceramics biomaterials have been widely used as load-bearing implants and internal fixation devices. However, polymer and bio-composites have substantial prospects in the medical field in soft tissue engineering. Even though many alloys and soft materials are generally trusted for biomedical applications, there is still room for improvement in imitating natural tissues and developing trust for large-scale adoption by the manufacturing society.
Hence, this Special Issue invites papers from mechanical, materials biomedical engineers, biomedical devices, and implants industries. The challenges related to safety and sales of devices/implants are also encouraged to contribute. For this purpose, we warmly welcome submissions, including regular research papers, short communications, and reviews describing current research trends and future perspectives.
The following topics, though not exclusively, fall within the scope of the Special Issue:
- Competence of new biomaterials with commercial ones
- Cost factor that hinders new biomaterials commercialization
- Clinical translation of the assets of biomedical engineering.
- Reproducibility, relevance, reliability, and credibility of biomedical technology translation.
- Nanoparticles for biomedical imaging: next step towards the industrial approach.
- Clinical translation of 3D printed scaffolds.
- Clinical translation of a high-performance neural prosthesis.
- Current challenges of bio-printed tissues toward clinical implementation.
- New regulations for 3D printed bio-implants.
- Novel alloy design for high biocompatibility.
- Composites and nature-inspired implants for scale-up manufacturing
- Low-cost biocompatible surface engineering.
- Additive manufacturing technology for advanced customized fabrication
Topic Editor, Arnab Chanda is the founder of Biofit Technologies. The other Topic Editors declare no competing interests with regard to the Research Topic subject.
This special issue focused on advancements in biomaterials and clinical translation. This issue intends to cover the recent improvement in designing and developing sustainable implants leading to their commercialization; however, innovation to commercialization is a giant step, and currently, the progress is almost at a standstill.
The researchers have explored various biomaterials to study alternatives to regeneration or replacement of damaged human tissue disease caused due to injury or chronic diseases such as diabetic ulcers, aneurysms, trauma injuries, etc.). The progress in emerging biomaterials has increased manifold in recent decades with the unprecedented focus on healthcare technologies and their commercialization. Because of their excellent mechanical strength, metallic and ceramics biomaterials have been widely used as load-bearing implants and internal fixation devices. However, polymer and bio-composites have substantial prospects in the medical field in soft tissue engineering. Even though many alloys and soft materials are generally trusted for biomedical applications, there is still room for improvement in imitating natural tissues and developing trust for large-scale adoption by the manufacturing society.
Hence, this Special Issue invites papers from mechanical, materials biomedical engineers, biomedical devices, and implants industries. The challenges related to safety and sales of devices/implants are also encouraged to contribute. For this purpose, we warmly welcome submissions, including regular research papers, short communications, and reviews describing current research trends and future perspectives.
The following topics, though not exclusively, fall within the scope of the Special Issue:
- Competence of new biomaterials with commercial ones
- Cost factor that hinders new biomaterials commercialization
- Clinical translation of the assets of biomedical engineering.
- Reproducibility, relevance, reliability, and credibility of biomedical technology translation.
- Nanoparticles for biomedical imaging: next step towards the industrial approach.
- Clinical translation of 3D printed scaffolds.
- Clinical translation of a high-performance neural prosthesis.
- Current challenges of bio-printed tissues toward clinical implementation.
- New regulations for 3D printed bio-implants.
- Novel alloy design for high biocompatibility.
- Composites and nature-inspired implants for scale-up manufacturing
- Low-cost biocompatible surface engineering.
- Additive manufacturing technology for advanced customized fabrication
Topic Editor, Arnab Chanda is the founder of Biofit Technologies. The other Topic Editors declare no competing interests with regard to the Research Topic subject.
